6
Views
0
CrossRef citations to date
0
Altmetric
Research Article

Literature Alerts

Pages 201-218 | Published online: 27 Sep 2008

References

  • , Biodegradation and tissue reaction to intravitreous biodegradable poly(D, L-lactic-co-glycolic) acid microspheres
  • Giordano G. G., Chevez-Barrios P. F., Refojo M. A, Garcia C. Curr. Eye. Res 1995; 14(9)761–768
  • , Sray-drying as a preparation method of microparticulate drug delivery systems: an overview
  • Giunchedi P., Conte U. STP Pharma. Prat 1995; 5(4)276–290
  • , Murine IgG subclass antibodies to antigens incorporated in liposomes containing lipid A
  • Glenn G. M., Rao M., Richards R. L., Matyas G. R., Alving C. R. Immunol. Lett 1995; 47(1–2)73–78
  • , Liposomal presentation of antigens for human vaccines
  • Gluck R. Pharm. Biotechnol 1995; 6: 325–345, Vaccine Design
  • , Programmable drug delivery from implants
  • Goepferich A, Langer R. Proc. Int. Symp. Controlled Release Bioact. Mater 1995, 22nd: 63–64
  • , Physiological responses, organ distribution, and circulation kinetics in anesthetized rats after hypovolemic exchange transfusion with technetium-99m-labeled liposome-encapsulated hemoglobin
  • Gins B., Klipper R., Sanders J., Cliff R. O., Rudolph A. S., Phillips W. T. Shock 1995; 4(2)121–130
  • , Biodegradable polymers for protein and peptide drug delivery
  • Gombotz W. R., Pettit D. K. Bioconjug. Chem 1995; 6(4)332–351
  • , Comparison of local intravascular drug-delivery catheter systems
  • Gonschior P., Pahl C., Huehns T. Y., Gerheuser F., Erdemci A., Larisch K., Dellian M., Deil S., Goetz A. E., Lehr H. A., et al. Am. Heart. J 1995; 130(6)1174–1181
  • , Liposomes as nasal drug delivery system
  • Goswami S., Vyas S. P. East. Pharm 1995; 38(453)33–36
  • , Local delivery of biodegradable microparticles containing colchicine or a colchicine analogue: effects on restenosis and implications for catheter-based drug delivery
  • Gradus P. I., Wilensky R. L., March K. L., Fineberg N., Michaels M., Sandusky G. E., Hathaway D. R. J. Am. Coll. Cardiol 1995; 26(6)1549–1557
  • , Drug delivery systems: water soluble taxol 2′-poly(ethylene glycol) ester prodrugs—design and in vivo effectiveness
  • Greenwald R. B., Gilbert C. W., Pendri A., Conover C. D., Xia J., Martinez A. J. Med. Chem 1996; 39(2)424–431
  • , Enhancement of protective immune responses to Venezuelan equine encephalitis (VEE) virus with microencapsulated vaccine
  • Greenway T. E., Eldridge J. H., Ludwig G., Staas J. K., Smith J. F., Gilley R. M., Michalek S. M. Vaccine 1995; 13(15)1411–1420
  • , The controlled intravenous delivery of drugs using PEG-coated sterically stabilized nanospheres
  • Gref R., Domb A., Quellec P., Blunk T., Mueller R. H., Verbavatz J. M., Langer R. Adv. Drug Delivery Rev 1995; 16(2,3)215–233
  • , Liposomes in vivo: control of behavior
  • Gregoriadis G. NATO ASI Ser 1994; 273(Ser A)113–118
  • , Engineering liposomes for drug delivery: progress and problems
  • Gregoriadis G. Trends Biotechnol 1995; 13(12)527–537
  • , Engineered liposomes and virosomes for delivery of macro-molecules
  • Grimaldi S., Giuliani A., Giuliani A., Ferroni L., Lisi A., Santoro N., Pozzi D. Res. Virol 1995; 146(4)289–293
  • , Compatibility of SVPs and LVPs with drug delivery systems
  • Guazzo D. M. PDA J. Pharm. Sci. Technol 1995; 49(6)305
  • , Drug delivery: piercing vesicles by their adsorption onto a porous medium
  • Guedeau-Boudeville M. A., Jullien L., di Meglio J. M. Proc. Natl. Acad. Sci. USA 1995; 92(21)9590–9592
  • , PLA-PEG micelles—a novel drug delivery system
  • Hagan S. A., Dunn S. E., Garnett M. C., Davies M. C., Ilium L., Davis S. S. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 194–1955
  • , Polymer microspheres for vaccine delivery
  • Hanes J., Chiba M., Langer R. Pharm. Biotechnol 1995; 6: 389–412, Vaccine Design
  • , Attachment of antibodies to sterically stabilized liposomes: evaluation, comparison and optimization of coupling procedures
  • Hansen C. B., Kao G. Y., Moase E. H., Zalipsky S., Allen T. M. Biochim. Biophys. Acta 1995; 1239(2)133–144
  • , Receptor-mediated transfer of pSV2CAT DNA to mouse liver cells using asialofetuin-labeled liposomes
  • Hara T., Aramaki Y., Takada S., Koike K., Tsuchiya S. Gene Ther 1995; 2(10)784–788
  • , Pharmacokinetic studies on the drug delivery system using liposomes
  • Harashima H. Yakubutsu Dotai 1995; 10(4)566–575
  • , Comparative pharmacokinetics, distributions in tissue, and interactions with blood proteins of conventional and sterically stabilized liposomes containing 2′,3′-dideoxyinosine
  • Harvie P., Desormeaux A., Bergeron M.-C., Tremblay M., Beauchamp D., Poulin L., Bergeron M. G. Antimicrob. Agents Chemother 1996; 40(1)225–229
  • , Fibrin binding of plasminogen coated liposomes in vitro
  • Heeremans J. L. M., Los P., Prevost R., Crommelin D. J. A., Kluft C. Thromb. Haemostasis 1996; 75(1)134–139
  • , Somatostatin containing biodegradable microspheres prepared by a modified solvent evaporation method based on W/O/W-multiple emulsions
  • Herrmann J., Bodmeier R. Int. J. Pharm 1995; 126(1,2)129–138
  • , Interferon-gamma-liposomes. Drug binding properties and in vitro antiviral activity
  • Hermann J., Stricker H. Eur. J. Pharm. Biopharm 1995; 41(6)361–368
  • , Biomodulation by hyperthermia of topoisomerase II-targeting drugs in human colorectal cancer cells
  • Hirohashi Y., Hidaka K., Sato S., Kuwano M., Kohno K., Hisatsugu T. Jpn. J. Cancer Res 1995; 86(11)1097–1105
  • , In vitro testing of crosslinked galactomannan coated tablets for site-specific drug delivery to the colon
  • Hirsch S., Schehlmann V., Kolter K., Betzing J., Bauer K. H. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 264–265
  • , Preparation of microemulsions using polyglycerol fatty acid esters as surfactant for the delivery of protein drugs
  • Ho H. O., Hsiao C. C., Sheu T, Ming T. J. Pharm. Sci 1996; 85(2)138–143
  • , Therapy-related acute promyelocytic leukemia with t(15; 17) (q22; q12) following chemotherapy with drugs targeting DNA topoisomerase. II. A report of two cases and a review of the literature (see comments)
  • Hoffmann L., Moller P., Pedersen-Bjergaard J., Waage A., Pedersen M., Hirsch F. R. Ann. Oncol 1995; 6(8)781–788
  • , Poly(ethylene glycol)-lipid conjugates regulate the calcium-induced fusion of liposomes composed of phosphatidylethanolamine and phosphatidylserine
  • Holland J. W., Hui C., Cullis P. R., Madden T. D. Biochemistry 1996; 35(8)2618–2624
  • , Localized drug delivery in atherosclerotic arteries via a new balloon angioplasty catheter with intramural channels for simultaneous local drug delivery
  • Hong M. K., Wong S. C., Farb A., Mehlman M. D., Virmani R., Barry J. J., Leon M. B. Cathet. Cardiovasc. Diagn 1995; 34(3)263–270
  • , Liposomal formulation of ciprofloxacin
  • Hope M. J., Wong K. W. Drug Targeting Delivery 1995; 6: 121–134
  • , Endocytosis of fluorescent microspheres by human oesophageal epithelial cells: comparison between normal and inflamed tissue
  • Hopwood D., Spiers E. M., Ross P. E., Anderson J. T., McCullough J. B., Murray F. E. Gut 1995; 37(5)598–602
  • , Cell cycle-dependent cytotoxicity and induction of apoptosis by liposomal N4-hexadecyl-1-β-D-arabinofuranosylcytosine
  • Horber D. H., von Ballmoos P., Schott H., Schwendener R. A. Br. J. Cancer 1995; 72(5)1067–1073
  • , Transplantation of microencapsulated islets in rats: influence of low temperature culture before or after the encapsulation procedure on the graft function
  • Horcher A., Siebers U., Bretzel R. G., Federlin K., Zekorn T. Transplant Proc 1995; 27(6)3232–3233
  • , Drug delivery studies in Caco-2 monolayers. IV. Absorption enhancer effects of cyclodextrins
  • Hovgaard L., Brondsted H. Pharm. Res 1995; 12(9)1328–1332
  • , Effects of free and liposomized praziquantel on worm burden and antibody response in mice infected with Mesocestoides corti tetrathyridia
  • Hrckova G., Velebny S. J. Helminthol 1995; 69(3)213–221
  • , Membrane compactness affects the integrity and immunoprotection of alginate-poly-L-lysine-alginate microcapsules
  • Hsu B. R., Ho Y. S., Fu S. H., Huang Y. Y., Chiou S. C., Huang H. S. Transplant Proc 1995; 27(6)3227–3231
  • , Endosomolytic activity of cationic liposomes enhances the delivery of human immunodeficiency virus-1 trans-activator protein (TAT) to mammalian cells
  • Huang L., Farhood H., Serbina N., Teepe A. G., Barsoum J. Biochem. Biophys. Res. Commun 1995; 217(3)761–768
  • , Microsphere transport pathways in the rabbit nasal mucosa
  • Huang Y., Donovan M. D. Int. J. Pharm. Adv 1996; 1(3)298–309
  • , The microencapsulation of protein using a novel ternary blend based on poly(epsilon-caprolactone)
  • Huatan H., Collett J. H., Attwood D. J. Microencapsul 1995; 12(5)557–567
  • , The antibody response to a prototype liposome vaccine containing Neisseria meningitidis outer membrane protein P1 produced in Bacillus subtilis
  • Idanpaan H. I., Muttilainen S., Wahlstrom E., Saarinen L., Leinonen M., Sarvas M, Makela P. H. Vaccine 1995; 13(16)1501–1508
  • , Influence of liposomal encapsulation on the penetration of retinoic acid through human skin in vitro
  • Imbert D., Kasting G. B., Wickett R. R. J. Soc. Cosmet. Chem 1994; 45(3)119–134
  • , A new drug delivery system using plasma-irradiated pharmaceutical aids. V. Controlled release of theophylline from plasma-irradiated double-compressed tablet composed of a wall material containing polybenzylmethacrylate
  • Ishikawa M., Noguchi T., Niwa J., Kuzuya M. Chem. Pharm. Bull. (Tokyo) 1995; 43(12)2215–2220
  • , Prevention of cataract development in selenite-induced cataract in rats by instillation of liposomes containing disulfiram and cefmetazole
  • Ito Y., Koizumi Y., Cai H., Negoro M., Terao M. Atarashii Ganka 1995; 12(11)1755–1762
  • , A novel drug delivery system for osteomyelitis using porous hydroxyapatite blocks loaded by centrifugation
  • Itokazu M., Matsunaga T., Kumazawa S., Yang W. J. Appl. Biomater 1995; 6(3)167–169
  • , Glutaraldehyde cross-linked chitosan microspheres as a long acting biodegradable drug delivery vehicle: studies on the in vitro release of mitoxantrone and in vivo degradation of microspheres in rat muscle
  • Jameela S. R., Jayakrishnan A. Biomaterials 1995; 16(10)769–775
  • , Targeting of drugs to tumors: the use of the plasminogen activator inhibitor as a ligand
  • Jankun J. NATO ASI Ser 1994; 273(Ser A)67–79
  • , Liposomes, drugs and industry
  • Janoff A. S. J. Liposome. Res 1995; 5(4)747–749
  • , Interfacial thickness of liposomes containing poly(ethylene glycol)- cholesterol from electrophoresis
  • Janzen J., Song X., Brooks D. E. Biophys. J 1996; 70(1)313–320
  • , Glutaraldehyde as a fixture in bioprostheses and drug delivery matrixes
  • Jayakrishnan A., Jameela S. R. Biomaterials 1996; 17(5)471–484
  • , Omega-3 fatty acid-containing liposomes in cancer therapy
  • Jenski L. J., Zerouga M., Stillwell W. Proc. Soc. Exp. Biol. Med 1995; 210(3)227–233
  • , Orally administered microencapsulated Bordetella pertussis fimbriae protect mice from B. pertussis respiratory infection
  • Jones D. H., McBride B. W., Thornton C., O'Hagan D. T., Robinson A., Farrar G. H. Infect. Immun 1996; 64(2)489–494
  • , Poly(lactide-co-glycolide) microencapsulation of vaccine antigens
  • Jones D. H., McBride B. W., Farrar G. H. J. Biotechnol 1996; 44(1–3)29–36
  • , Assessment of liposomal transfection of ocular tissues in vivo
  • Jones S. E., McHugh J. D., Jomary C., Shallal A., Neal M. J. Gene Ther 1994; 1(11)S61
  • , Biomedical materials, devices and drug delivery systems by radiation techniques
  • Kaetsu I. Radiat. Phys. Chem 1996; 47(3)419–424
  • , Blood-brain barrier. From static wall to dynamic interface. Recent advances in drug delivery to the brain. Part 4
  • Kakee A., Terasaki T., Kitazawa T., Tsuji A., Sugiyama Y. Pharm. Tech. Jpn 1995; 11(11)1321–1326; 1329–1333
  • , Blood-brain barrier. From static wall to dynamic interface. Recent advances in drug delivery to the brain. Part 5
  • Kakee A., Terasaki T., Kitazawa T., Tsuji A., Sugiyama Y. Pharm. Tech. Jpn 1996; 12(1)19–32
  • , Liposome and multiple emulsion formulations augment the anticalcifying efficacy of phosphocitrate in a cutaneous calcergy model
  • Kamperman H., Sallis J. D. J. Pharm. Pharmacol 1995; 47(10)802–807
  • , Induction of hepatitis in rats injected with HBV-DNA using HVJ-liposome
  • Kaneda Y. Nippon Rinsho 1995; 53: 104–110, Suppl
  • , Application of curdlan to controlled drug delivery. II. In vitro and in vivo drug release studies of theophyllinecontaining curdlan tablets
  • Kanke M., Katayama H., Nakamura M. Biol. Pharm. Bull 1995; 18(8)1104–1108
  • , Application of curdlan to controlled drug delivery. III. Drug release from sustained release suppositories in vitro
  • Kanke M., Tanabe E., Katayama H., Koda Y., Yoshitomi H. Biol. Pharm. Bull 1995; 18(8)1154–1158
  • , The use of the Rank electrode for the detection of the activity of liposomally encapsulated enzymes
  • Kaszuba M., Taylor M. A., Jones M. N. Biochem. Soc. Trans 1995; 23(4)568S
  • , Enhanced in vivo performance of liposomal indomethacin derived from effervescent granule based proliposomes
  • Katare O. P., Vyas S. P., Dixit V. K. J. Microencapsul 1995; 12(5)487–493
  • , Targeted cancer chemotherapy with arterial microcapsule chemoembolization: review of 1013 patients
  • Kato T., Sato K., Sasaki R., Kakinuma H., Moriyama M. Cancer Chemother. Pharmacol 1996; 37(4)289–296
  • , Drug delivery system (DDS) responsive to intravital environment and new development using biodegradable polymer
  • Kawabuchi M., Okano T., Sugihara M. Nippon Yakuzaishikai Zasshi 1995; 47(10)1611–1618
  • , Preparation and in-vitro evaluation of sustained-release metoclopramide hydrochloride microspheres
  • Khidr S. H., Niazy E. M., El Sayed Y. M. J. Microencapsul 1995; 12(6)651–660
  • , Self assembling nanostructures for sustained ophthalmic drug delivery
  • Khopade A. J., Jain N. K. Pharmazie 1995; 50(12)812–814
  • , Polymerized liposomes
  • Khopade A. J., Mahadik K. R., Kadam S. S. East. Pharm 1995; 38(451)21–24
  • , Lymphatic delivery and pharmacokinetics of methotrexate after intramuscular injection of differently charged liposome-entrapped methotrexate to rats
  • Kim C. K., Han J. H. J. Microencapsul 1995; 12(4)437–446
  • , Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. 1. Stability studies for hairless rat skin permeation
  • Kim D. D., Chien Y. W. J. Pharm. Sci 1995; 84(9)1061–1066
  • , Transdermal delivery of dideoxynucleoside-type anti-HIV drugs. 2. The effect of vehicle and enhancer on skin permeation
  • Kim D. D., Yie W. C. J. Pharm. Sci 1996; 85(2)214–219
  • , Response to liposome-encapsulated doxorubicin (TLC D-99) in a dog with myeloma
  • Kisseberth W. C., MacEwen E. G., Helfand S. C., Vail D. M., London C. L., Keller E. J. Vet. Intern. Med 1995; 9(6)425–428
  • , A total delivery system of genetically engineered drugs or cells for diseased vessels. Concept, materials, and fabricated prototype device
  • Kito H., Suzuki T., Nagahara S., Nakayama Y., Tsutsui Y., Isutsui N., Nakajima N., Matsuda T. ASAIO-J 1994; 40(3)M260–266
  • , Biologic therapy for osteosarcoma using liposomeencapsulated muramyl tripeptide
  • Kleinerman E. S. Hematol. Oncol. Clin. North. Am 1995; 9(4)927–938
  • , Spontaneous transfer of viral protein from membrane of influenza virus-infected cells to liposomes is dependent on the diameter of receiver
  • Kogure K., Itoh M., Hayashi K., Ueno M. Biol. Pharm. Bull 1995; 18(8)1168–1170
  • , Synthesis of polypeptides with fusogenic activity and their application to drug delivery system
  • Kono K. Asahi Garasu Zaidan Josei Kenkyu Seika Hokoku 1995; 317–324
  • , Successful reversal of diabetes in nude mice by transplantation of microencapsulated porcine neonatal islet cell aggregates
  • Korbutt G. S., Ao Z., Warnock G. L., Flashner M., Rajotte R. V. Transplant Proc 1995; 27(6)3212
  • , Water-in-fluorocarbon emulsions for drug delivery
  • Krafft M. P., Sadtler V., Riess J. G. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 464–465
  • , Rapid high-yield purification and liposome reconstitution of polyhistidine-tagged sensory rhodopsin I
  • Krebs M. P., Spudich E. N., Spudich J. L. Protein Expression Purif 1995; 6(6)780–788
  • , Nanoparticulate systems in drug delivery and targeting
  • Kreuter J. J. Drug Targeting 1995; 3(3)171–173
  • , Experience with liposomal Amphotericin-B in 60 patients undergoing high-dose therapy and bone marrow or peripheral blood stem cell transplantation
  • Kruger W., Stockschlader M., Russmann B., Berger C., Hoffknecht M., Sobottka I., Kohlschutter B., Kroschke G., Kroger N., Horstmann M., et al. Br. J. Haematol 1995; 91(3)684–690
  • , Polymers as drug carriers: controlled delivery devices—a review
  • Kumar S., Ali A. Indian J. Hosp. Pharm 1995; 32(4)129–133
  • , Pharmacodynamics of liposomes
  • Kumar S., Khar R. K., Sharma S. N., Chauhan U. P. S. East. Pharm 1995; 38(445)39–43
  • , Liposome-encapsulated (S)-1-(3-hydroxy-2-phosphonylmethoxypropyl) cytosine for long-acting therapy of viral retinitis
  • Kuppermann B. D., Assil K. K., Vuong C., Besen G., Wiley C. A., De Clercq E., Bergeron L. G., Connor J. D., Pursley M., Munguia D., Freeman W. R. J. Infect. Dis 1996; 173(1)18–23
  • , Lipid emulsions for parenteral drug delivery of lipophilic antitumor agents
  • Kurihara A., Yamashita Y., Mizota A., Yasuno A., Ikeda M., Sasagawa K., Kobayashi T., Hisaoka M. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 402–403
  • , Cardiac function of an acute ischemic heart failure model produced by microsphere injection into the left coronary artery. Pressure-volume relationship as determined by a conductance catheter
  • Kuroda H., Suga H. ASAIO-J 1995; 41(4)855–862
  • , A new drug delivery system using plasma-irradiated pharmaceutical aids. VI. Controlled release of theophylline from plasma-irradiated double-compressed tablet composed of water-soluble polymers as a wall material
  • Kuzuya M., Ishikawa M., Noguchi T., Niwa J., Kondo S. Chem. Pharm. Bull. (Tokyo) 1996; 44(1)192–195
  • , Cytokine-containing liposomes as adjuvants for HIV sub-unit vaccines
  • Lachman L. B., Shih L. C., Rao X. M., Hu X., Bucana C. D., Ullrich S. E., Cleland J. L. AIDS Res. Hum. Retroviruses 1995; 11(8)921–932
  • , Cytokine-containing liposomes as adjuvants for subunit vaccines
  • Lachman L. B., Shih L. C., Rao X. M., Ullrich S. E., Cleland J. L. Pharm. Biotechnol 1995; 6: 659–671, Vaccine Design
  • , Transplantation of porcine and bovine islets into mice without immunosuppression using uncoated alginate micro-spheres
  • Lanza R. P., Kuhtreiber W. M., Ecker D. M., Marsh J. P., Chick W. L. Transplant Proc 1995; 27(6)3321
  • , Transmembrane gradient driven phase transitions within vesicles: lessons for drug delivery
  • Lasic D. D., Ceh B., Stuart M. C., Guo L., Frederik P. M., Barenholz Y. Biochim. Biophys. Acta 1995; 1239(2)145–156
  • , Physicochemical, pharmacokinetic and pharmacodynamic evaluation of liposomal tacrolimus (FK 506) in rats
  • Lee M. J., Straubinger R. M., Jusko W. J. Pharm. Res 1995; 12(7)1055–1059
  • , Peptide and protein drug delivery: past, present and future
  • Lee V. H. L. Drug Targeting Delivery 1995; 4: 3–19
  • , Effects of β-cyclodextrins on skin: implications for the transdermal delivery of piribedil and a novel cognition enhancing drug, S-9977
  • Legendre J. Y., Rault I., Petit A., Luijten W., Demuynck I., Horvath S., Ginot Y. M., Cuine A. Eur. J. Pharm. Sci 1995; 3(6)311–322
  • , In vitro study for the assessment of poly(L-aspartic acid) as a drug carrier for colon-specific drug delivery
  • Leopold C. S., Friend D. R. Int. J. Pharm 1995; 126(1,2)139–145
  • , Prediction of solvent removal profile and effect on properties for peptide-loaded PLGA microspheres prepared by solvent extraction/evaporation method
  • Li W. I., Anderson K. W., Mehta R. C., DeLuca P. P. J. Controlled Release 1995; 37(3)199–214
  • , Surface modification of phospholipid liposomes by incorporation of glycolipid
  • Li Z. C., He W., Li F. M. Chin. Chem. Lett 1995; 6(11)947–950
  • , Interactions of Ca2+ with phospholipid liposomes containing beta-eleostearic acid
  • Li Z., He W., Li F. Shengwu Wuli Xuebao 1995; 11(3)362–366
  • , Liposome-encapsulated silver sulfadiazine (SSD) for the topical treatment of infected burns: thermodynamics of drug encapsulation and kinetics of drug release
  • Lichtenstein A., Margalit R. J. Inorg. Biochem 1995
  • 60(3)187–198
  • , Targeting of teniposide to the mononuclear phagocytic system (MPS) by incorporation in liposomes and submicron lipid particles; an autoradiographic study in mice
  • Liliemark E., Sjostrom B., Liliemark J., Peterson C., Kallberg N., Larsson B. S. Leuk. Lymphoma 1995; 18(1–2)113–118
  • , Development of local drug delivery system: prolonged sciatic nerve blockade from biodegradable microspheres
  • Lim J. Yakche Hakhoechi 1995; 25: S33–S35, 3, Suppl.
  • , Cytotoxic effect of calcein acetoxymethylester on human tumor cell lines: drug delivery by intracellular trapping
  • Liminga G., Nygren P., Dhar S., Nilsson K., Larsson R. Anticancer Drugs 1995; 6(4)578–585
  • , Liposome clearance from blood: different animal species have different mechanisms
  • Liu D., Hu Q., Song Y. K. Biochim. Biophys. Acta 1995; 1240(2)277–284
  • , Antibody dependent, complement mediated liver uptake of liposomes containing GM1
  • Liu D., Song Y. K., Liu F. Pharm. Res 1995; 12(11)1775–1780
  • , Lung annexin II promotes fusion of isolated lamellar bodies with liposomes
  • Liu L., Fisher A. B., Zimmerman U. J. Biochim. Biophys. Acta 1995; 1259(2)166–172
  • , Accumulation of protein-coated liposomes in an extravascular site: influence of increasing carrier circulation lifetimes
  • Longman S. A., Tardi P. G., Parr M. J., Choi L., Cullis P. R., Bally M. B. J. Pharmacol. Exp. Ther 1995; 275(3)1177–1184
  • , A model approach for assessing liposome targeting in vivo
  • Longman S. A., Cullis P. R., Bally M. B. Drug Delivery 1995; 2(3/4)156–165
  • , Botulinum toxin type A inhibits Ca(2+)-dependent transport of acetylcholine in reconstituted giant liposomes made from presynaptic membranes from cholinergic nerve terminals
  • Lopez-Alonzo E., Canaves J., Arribas M., Casanova A., Marsal J., Gonzalez-Ros J. M., Solsona C. Neurosci. Lett 1995; 196(1–2)37–40
  • , Mucoadhesive polymers in peroral peptide drug delivery. II. Carbomer and polycarbophil are potent inhibitors of the intestinal proteolytic enzyme trypsin
  • Luessen H. L., Verhoef J. C., Borchard G., Lehr C. M., De Boer A. G., Junginger H. E. Pharm. Res 1995; 12(9)1293–1298
  • , Concentration dependence of liposomes-water partition coefficient of hydroxyphenyl fatty acid derivatives
  • Lurie E. Y., Kaplun A. P., Vasilenko I. A., Dubovski P. V., Shvets V. I. Biol. Membr 1995; 12(5)546–552
  • , Characterization of microstructures in drug delivery systems by EPR spectroscopy
  • Mader K., Bacic G., Domb A., Swartz H. M. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 780–781
  • , Physicochemical and pharmacokinetic characteristics of plasmid DNA /cationic liposome complexes
  • Mahato R. I., Kawabata K., Nomura T., Takakura Y., Hashida M. J. Pharm. Sci 1995; 84(11)1267–1271
  • , In vivo disposition characteristics of plasmid DNA cornplexed with cationic liposomes
  • Mahato R. I., Kawabata K., Takakura Y., Hashida M. J. Drug Target 1995; 3(2)149–157
  • , Effects of orally administered liposomes with soybean-derived sterols and their glucosides on rat body weight
  • Maitani Y., Hazama M., Tojo H., Qi X. R., Nagai T. Biol. Pharm. Bull 1995; 18(11)1551–1555
  • , Treatment of vascular disease with local drug delivery systems
  • Makkar R. R., Litvack F., Eigler N., Forrester J. S. Cardiologia 1995; 40(9)651–657
  • , The effect of free gallium and gallium in liposomes on cytokine and nitric oxide secretion from macrophage-like cells in vitro
  • Makkonen N., Hirvonen M. R., Savolainen K., Lapinjoki S., Moenkkoenen J. Inflammation Res 1995; 44(12)523–528
  • , Transdermal drug delivery systems
  • Mandal S. C., Bhattacharyya M. East. Pharm 1994; 37(440)57–60
  • , Liposomal prostaglandin E1 in acute respiratory distress syndrome: a placebo-controlled, randomized, double-blind, multicenter clinical trial
  • Abraham E., Park Y. C., Covington P., Conrad S. A., Schwartz M. Crit. Care. Med 1996; 24(1)10–15
  • , Preparation and evaluation of sustained release AZT-loaded microspheres: optimization of the release characteristics using response surface methodology
  • Abu I. K. A., Garcia-Contreras L., Lux D. R. J. Pharm. Sci 1996; 85(2)144–149
  • , Growth retardation—an unexpected outcome from growth hormone gene therapy in normal mice with microencapsulated myoblasts
  • Al-Hendy A., Hortelano G., Tannenbaum G. S., Chang P. L. Hum. Gene. Ther 1996; 7(1)61–70
  • , Liposome-mediated gene transfer and expression via the skin
  • Alexander M. Y., Akhurst R. J. Hum. Mol. Genet 1995; 4(12)2279–2285
  • , Antimetastatic effect of immunization with liposomeencapsulated tumor cell-membrane proteins obtained from experimental tumors
  • Alino S. F., Lejarreta M., Alfaro J., Iruarrizaga A., Bobadilla M., Blaya C., Crespo J. Immunopharmacol. Immunotoxicol 1995; 17(3)419–436
  • , Drugs, devices and delivery considerations in parenteral pharmaceutical care, or, what are they doing with our drugs?
  • Allen L. V., Jr. PDA. J. Pharm. Sci. Technol 1995; 49(6)306–308
  • , Immunoliposome-mediated targeting of anti-cancer drugs in vivo
  • Allen T. M., Ahmad I., Lopes De Menezes D. E., Moase E. H. Biochem. Soc. Trans 1995; 23(4)1073–1079
  • , Passive targeting of anthracyclines entrapped in long-circulating (stealth) liposomes in the treatment of cancer
  • Allen T. M. NATO ASI Ser., Ser A 1994; 273: 119–128
  • , A new strategy for attachment of antibodies to sterically stabilized liposomes resulting in efficient targeting to cancer cells
  • Allen T. M., Brandeis E., Hansen C. B., Kao G. Y., Zalipsky S. Biochim. Biophys. Acta 1995; 1240(2)285
  • , Flirtations with membranes, liposomes and lipoproteins
  • Allison A. C. J. Liposome. Res 1995; 5(4)641–655
  • , Influence of free or liposomal amphotericin B on killing of Candida species by human peritoneal macrophages
  • Allwinn R., Schaumann R., Shah P. M. Methods. Find. Exp. Clin. Pharmacol 1995; 17(3)163–167
  • , A study on bromocriptine-silicone elastomer matrix system for controlled drug delivery
  • Altug N., Acarturk F. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 736–737
  • , Design and evaluation of tansdermal chlorpheniramine maleate drug delivery system
  • Andronis V., Mesiha M. S., Plakogiannis F. M. Pharm. Acta. Helv 1995; 70(4)301–306
  • , Antibacterial activity of liposomal amikacin against Pseudomonas aeruginosa in vitro
  • Antos M., Trafny E. A., Grzybowski J. Pharmacol. Res 1995; 32(1/2)85–87
  • , Microencapsulation improves canine islet survival in vivo
  • Ao Z., Korbutt G. S., Warnock G. L., Flashner M., Colby C. B., Luskey K. L., Rajotte R. V. Transplant. Proc 1995; 27(6)3349
  • , Microencapsulation enhances canine islet survival during long-term culture
  • Ao Z., Korbutt G. S., Warnock G. L., Flashner M., Colby C. B., Rajotte R. V. Transplant. Proc 1995; 27(6)3350
  • , Interferon-γ inductive effect of liposomes as an immunoad-juvant
  • Aramaki Y., Suda H., Tsuchiya S. Vaccine 1995; 13(18)1809–1814
  • , Characterization, in vitro and in vivo studies on primaquine diphosphate liposomes
  • Arica B., Ozer A. Y., Ercan M. T., Hincal A. A. J. Microencapsul 1995; 12(5)469–485
  • , Covalent immobilization of alpha-amylase onto pHEMA microspheres: preparation and application to fixed bed reactor
  • Arica M. Y., Hasirci V., Alaeddinoglu N. G. Biomaterials 1995; 16(10)761–768
  • , Cholate-induced disruption of calcitonin-loaded liposomes: formation of trypsin-resistant lipid-calcitonin-cholate complexes
  • Arien A., Toulme H. N., Dupuy B. Pharm. Res 1995; 12(9)1289–1292
  • , Physical stability of different liposome compositions obtained by extrusion method
  • Armengol X., Estelrich J. J. Microencapsul 1995; 12(5)525–535
  • , Liposomal muramyl tripeptide upregulates adhesion molecules on the surface of human monocytes
  • Asano T., McIntyre B. W., Bednarczyk J. L., Wygant J. N., Kleinerman E. S. Oncol. Res 1995; 7(5)253–257
  • , Phagocytosis of monosize polystyrene-based microspheres having different size and surface properties
  • Ayhan H., Tuncel A., Bor N., Picskin E. J. Biomater. Sci. Polym. Ed 1995; 7(4)329–342
  • , Interaction of cationic liposomes with cells of electrically active neuronal networks in culture
  • Azzazy H. M., Hong K., Wu M. C., Gross G. W. Brain Res 1995; 695(2)231–236
  • , Possibility of magnetic targeting of drugs using magnetoliposomes
  • Babincova M., Babinec P. Pharmazie 1995; 50(12)828–829
  • , Influence of ionic strength on polyethylene glycol induced liposome aggregation
  • Babincova M. Pharmazie 1995; 50(12)831
  • , Albumin-heparin microspheres as a drug delivery carrier
  • Bae Y. H., Kwon G., Cremers H., Kim S. W., Feijen J. Yakche Hakhoechi 1995; 25: S21–S32, 3, Suppl.
  • , Targeting of peptide and protein drugs to specific sites in the oral route
  • Bai J. P. F., Chang L. L., Guo J. H. Crit. Rev. Ther. Drug Carrier Syst 1995; 12(4)339–371
  • , Liposomes modulate Kupffer cell endotoxin response
  • Bankey P., Beecherl E., Bibus D., See D., McIntyre K. Arch. Surg 1995; 130(12)1266–1272
  • , The transfer of antioxidants between liposomes
  • Barclay L. R. C., McLaughlin K. A., Vinqvist M. R. J. Liposome Res 1995; 5(4)955–979
  • , Biodegradable in-situ polymerizable macromonomers as matrixes for targeted drug delivery
  • Barman S. P., Coury A., Pathak C. P. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 784–785
  • , Interaction of PEG-phospholipid conjugates with phospholipid: implications in liposomal drug delivery
  • Bedu A. F. K., Huang L. Adv. Drug Delivery Rev 1995; 16(2,3)235–247
  • , Liposome-incorporated dexamethasone palmitate inhibits in-vitro lymphocyte response to mitogen
  • Benameur H., Latour N., Schandene L., van Vooren J. P., Flamion B., Legros F. J. J. Pharm. Pharmacol 1995; 47(10)812–817
  • , Treatment of Kaposi's sarcoma with liposomal doxorubicin
  • Bergin C., O'Leary A., McCreary C., Sabra K., Mulcahy F. Am. J. Health. Syst. Pharm 1995; 52(18)2001–2004
  • , Percutaneous absorption of a new antiandrogen included in liposomes or in solution
  • Bernard E., Dubois J. L., Wepierre J. Int. J. Pharm 1995; 126(1,2)235–243
  • , An approach to the formulation of a transdermal drug delivery system of promethazine hydrochloride
  • Bhatt D. C., Agrawal G. P. East. Pharm 1995; 38(453)145–147
  • , Estimation of the H+/H-ratio of the reaction catalysed by the nicotinamide nucleotide transhydrogenase in chromatophores from over-expressing strains of Rhodospirillum rubrum and in liposomes inlaid with the purified bovine enzyme
  • Bizouarn T., Sazanov L. A., Aubourg S., Jackson J. B. Biochim. Biophys. Acta 1996; 1273(1)4–12
  • , Gene therapy—a novel form of drug delivery
  • Blau H. M., Springer M. L. N. Engl. J. Med 1995; 333(18)1204–1207
  • , Polymeric microspheres prepared by spraying into compressed carbon dioxide
  • Bodmeier R., Wang H., Dixon D. J., Mawson S., Johnston K. P. Pharm. Res 1995; 12(8)1211–1217
  • , Liposome-entrapped antimicrobial agents for abdominal infection
  • Bohnen J. M. A. Drug Targeting Delivery 1995; 6: 135–145
  • , Vincristine-induced dermal toxicity is significantly reduced when the drug is given in liposomes
  • Boman N. L., Tron V. A., Bally M. B., Cullis P. R. Cancer. Chemother. Pharmacol 1996; 37(4)351–355
  • , Intragastric distribution of ion-exchange resins: a drug delivery system for the topical treatment of the gastric mucosa
  • Burton S., Washington N., Steele R. J. C., Musson R., Feely L. J. Pharm. Pharmacol 1995; 47(11)901–906
  • , Sustained release of liposome-encapsulated enrofloxacin after intramuscular administration in rabbits
  • Cabanes A., Reig F., Anton J. M., Arboix M. Am. J. Vet. Res 1995; 56(11)1498–1501
  • , Adsorption of salmon calcitonin to PLGA microspheres
  • Calis S., Jeyanthi R., Tsai T., Mehta R. C., DeLuca P. P. Pharm. Res 1995; 12(7)1072–1076
  • , In vitro liposome-mediated DNA transfection of epithelial cell lines using the cationic liposome DC-Choi/DOPE
  • Caplen N. J., Kinrade E., Sorgi F., Gao X., Gruenert D., Geddes D., Coutelle C., Huang L., Alton E. W., Williamson R. Gene Ther 1995; 2(9)603–613
  • , Bacterial enzymes used for colon-specific drug delivery are decreased in active Crohn's disease
  • Carrette O., Favier C., Mizon C., Neut C., Cortot A., Colombel J. F., Mizon J. Dig. Dis. Sci 1995; 40(12)2641–2646
  • , Blends of synthetic and natural polymers as drug delivery systems for growth hormone
  • Cascone M. G., Sim B., Downes S. Biomaterials 1995; 16(7)569–574
  • , Drug forms for drug delivery into the gastrointestinal tract
  • Chalabala M., Rak J., Vitkova M., Hederova S. Ceska. Slov. Farm 1995; 44(5)242–245
  • , Stabilization of tetanus toxoid in poly(DL-lactic-co-glycolic acid) microspheres for the controlled release of antigen
  • Chang A. C., Gupta R. K. J. Pharm. Sci 1996; 85(2)129–132
  • , Liposomal entrapment of suramin(II): interaction of suramin with phospholipids of various chain lengths
  • Chang H. C., Flanagan D. R. J. Pharm. Sci 1995; 84(9)1078–1082
  • , Differential effect of triiodothyronine and thyroxine on liposomes containing cholesterol: physiological speculations
  • Chehin R. N., Rintoul M. R., Morero R. D., Farias R. N. J. Membr. Biol 1995; 147(2)217–221
  • , Heat-mediated selective delivery of liposome-associated melphalan in murine melanoma
  • Chelvi P. T., Jain S. K., Ralhan R. Melanoma. Res 1995; 5(5)321–326
  • , Hyperthermia-mediated targeted delivery of thermosensitive liposome-encapsulated melphalan in murine tumors
  • Chelvi T. P., Jain S. K., Ralhan R. Oncol. Res 1995; 7(7/8)393–398
  • , Novel hydrogels of a temperature-sensitive Pluronic grafted to a bioadhesive polyacrylic acid backbone for vaginal drug delivery
  • Chen G., Hoffman A. S., Ron E. S. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 167–168
  • , Polysaccharide hydrogels for protein drug delivery
  • Chen J., Jo S., Park K. Carbohydr. Polym 1995; 28(1)69–76
  • , Study of microencapsulation for pituitary transplantation: capsule preparation and in vitro study
  • Chen Z. P., Bao Y. D., Gorczyca W., Mohr G. Artif. Cells. Blood Substit. Immobil. Biotechnol 1995; 23(5)597–604
  • , Oral immunization with dehydrated liposomes containing
  • , Streptococcus mutans glucosyltransferase (GTF) in humans
  • Childers N. K., Zhang S. S., Michalek S. M. Adv. Exp. Med. Biol 1995; 371B: 1481–1484
  • , Engineered chimeric streptavidin tetramers as novel tools for bioseparations and drug delivery
  • Chilkoti A., Schwartz B. L., Smith R. D., Long C. J., Stayton P. S. Bio/Technology 1995; 13(11)1198–1204
  • , Phase separated membranes for transdermal drug delivery system
  • Cho C. S., Choi S. H., Bae Y. H., Kim S. W. Drug Delivery Syst 1995; 10(6)437–444
  • , Peptide drug delivery: a method to overcome enzymic barrier
  • Choi H. Yakche Hakhoechi 1995; 25: S37–S42, 3, Suppl.
  • , Liposomal cyclosporine. Comparison of drug and lipid carrier pharmacokinetics and biodistribution
  • Choice E., Masin D., Bally M. B., Meloche M., Madden T. D. Transplantation 1995; 60(9)1006–1011
  • , Recent advances in liposomal drug-delivery systems
  • Chonn A., Cullis P. R. Curr. Opin. Biotechnol 1995; 6(6)698–708
  • , Drug targeting by magnetically responsive microspheres
  • Chopra K. S., Singla D. East. Pharm 1994; 37(440)79–82
  • , Heat sterilization of archaeal liposomes
  • Choquet C. G., Patel G. B., Sprott G. D. Can. J. Microbiol 1996; 42(2)183–186
  • , Rapid diffusion of the lipid phosphorus of phosphatidylglycerol liposomes through polycarbonate membranes is caused by the oxidation of the unsaturated fatty acids
  • Chow C. Y., Heath T. D. Biochim. Biophys. Acta 1995; 1239(2)168–176
  • , Transdermal drug delivery: a review of current status
  • Chowdary K. P. R., Naidu R. A. S. Indian Drugs 1995; 32(9)414–422
  • , Microencapsulation of solid dispersions of nifedipine—a novel approach for controlling drug release
  • Chowdary K. P. R., Ramesh K. V. R. N. S. Indian Drugs 1995; 32(10)477–483
  • , Design and production of single-immunization vaccines using polylactide polyglycolide microsphere systems
  • Cleland J. L. Pharm. Biotechnol 1995; 6: 439–462, Vaccine Design
  • , Loading of amphipathic weak acids into liposomes in response to transmembrane calcium acetate gradients
  • Clerc S., Barenholz Y. Biochim. Biophys. Acta 1995; 1240(2)257–265
  • , A comparative study of the accurate measurement of endotoxin in liposome-encapsulated hemoglobin
  • Cliff R. O., Kwasiborski V., Rudolph A. S. Artif. Cells. Blood. Substit. Immobil. Biotechnol 1995; 23(3)331–336
  • , Successful xenografts in mice with microencapsulated rat and dog islets
  • Cochrum K., Jemtrud S., Dorian R. Transplant. Proc 1995; 27(6)3297–3301
  • , Novel liposome-based formulations for prolonged delivery of proteins and vaccines
  • Cohen S., Langer R. J. Liposome Res 1995; 5(4)813–827
  • , Effects of liposome-entrapped platelet-activating factor in the isolated rat trachea
  • Costuleanu M., Brailoiu E., Filipeanu C. M., Baltatu O., Slatineanu S., Saila L., Nechifor M., Branisteanu D. D. Eur. J. Pharmacol 1995; 281(1)89–92
  • , Programmable oral release technology, PORT Systems: a novel dosage form for time and site specific oral drug delivery
  • Crison J. R., Siersma P. R., Taylor M. D., Amidon G. L. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 278–279
  • , Site specific microencapsulated drug targeting strategies—liver and gastrointestinal tract targeting
  • DeSouza M. J., DeSouza P. Adv. Drug Delivery Rev 1995; 17(3)247–254
  • , Opportunities in targeted drug delivery to Kupffer cells: delivery of immunomodulators to Kupffer cells—activation of tumoricidal properties
  • Daemen T., Hoedemakers R., Storm G., Scherphof G. L. Adv. Drug Delivery Rev 1995; 17(1)21–30
  • , Gene therapy for donor hearts: ex vivo liposome-mediated transfection
  • Dalesandro J., Akimoto H., Gorman C. M., McDonald T. O., Thomas R., Liggitt H. D., Allen M. D. J. Thorac. Cardiovasc. Surg 1996; 111(2)416–421
  • , Influence of pH adjustment on microcapsules obtained from complex coacervation of gelatin and acacia
  • Daniels R., Mittermaier E. M. J. Microencapsul 1995; 12(6)591–599
  • , Particulate systems for site specific drug delivery
  • Davis S. S., Illum L. NATO ASI See, Ser A 1994; 273: 183–194
  • , Liposomes as an immunoadjuvant system for stimulation of mucosal and systemic antibody responses against inactivated measles virus administered intranasally to mice
  • De Haan A., Tomee J. F., Huchshorn J. P., Wilschut J. Vaccine 1995; 13(14)1320–1324
  • , Sustained release of phenylpropanolamine hydrochloride using a novel controlled release drug delivery system
  • Desai A. J., Caldwell H. C., Amber A. S. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 298–299
  • , Pilocarpine bioavailability from microspheres: ophthalmic drug delivery system
  • Deshpande S. G., Rathod S. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 406–407
  • , Kinetics of drug delivery to the arterial wall via polyurethane-coated removable nitinol stent: comparative study of two drugs
  • Dev V., Eigler N., Sheth S., Lambert T., Forrester J., Litvack F. Cathet. Cardiovasc. Diagn 1995; 34(3)272–278
  • , Double shell microspheres as protein carrier
  • Dinella C., Laus M., Stagni A., Doria M., Lanzarini G. Meded. Fac. Landbouwkd Toegepaste Biol. Wet. (Univ. Gent) 1995; 60: 1999–2002, 4a, Forum for Applied Biotechnology, Part 1
  • , Ginseng saponin liposome (GSL)
  • Ding Y., Ma S., Lu X., Wang H., Huo Y. Zhongguo Yaoxue Zazhi 1995; 30(7)414–417
  • , Transplantation of microencapsulated hepatocytes for liver function replacement
  • Dixit V., Gitnick G. J. Biomater. Sci. Polym. Ed 1995; 7(4)343–357
  • , Study on transnasal aspirin-dl-lysine liposome
  • Dong Z. Zhongguo Yiyao Gongye Zazhi 1995; 26(5)199–202
  • , Treatment of invasive pulmonary aspergillosis in severely neutropenic children with malignant disorders using liposomal amphotericin B (AmBisome), granulocyte colony-stimulating factor, and surgery: report of five cases
  • Dornbusch H. J., Urban C. E., Pinter H., Ginter G., Fotter R., Becker H., Miorini T., Berghold C. Pediatr. Hematol. Oncol 1995; 12(6)577–586
  • , Liposome-mediated therapy of human immunodeficiency virus type-1 and Mycobacterium infections
  • Duezguenes N., Flasher D., Pretzer E., Konopka K., Slepushkin V. A., Steffan G., Salem I. I., Reddy Venkata M. G., Pattisapu R. J. J. Liposome Res 1995; 5(4)669–691
  • , Precorneal clearance of mucoadhesive microspheres from the rabbit eye
  • Durrani A. M., Farr S. J., Kellaway I. W. J. Pharm. Pharmacol 1995; 47(7)581–584
  • , Physicochemical properties of cimetidine magnetic micro-spheres
  • Dutta U. K., Ghosal S. K., Pal T. K. Indian Drugs 1995; 32(10)484–487
  • , The transfer of polystyrene microspheres from the gastrointestinal tract to the circulation after oral administration in the rat
  • Eyles J., Alpar O., Field W. N., Lewis D. A., Keswick M. J. Pharm. Pharmacol 1995; 47(7)561–565
  • , Liposomal formulations of cyclosporin A: influence of lipid type and dose on pharmacokinetics
  • Fahr A., Holz M., Fricker G. Pharm. Res 1995; 12(8)1189–1198
  • , The evolving role of the liposome in gene delivery
  • Feigner P. L. J. Liposome Res 1995; 5(4)725–734
  • , Preparation and characterization of liposomal adriamycin
  • Feng B., Lang J., Li D. Zhonghua Yixue Zazhi 1995; 75(10)614–616
  • , Theoretical model of iontophoresis utilized in transdermal drug delivery
  • Ferry L. L. Pharm. Acta. Helv 1995; 70(4)279–287
  • , Preparation and characterization of dipalmitoylphosphatidylcholine liposomes containing interleukin-2
  • Fleury L., Ollivon M., Dubois J. L., Puisieux F., Barratt G. Braz. J. Med. Biol. Res 1995; 28(5)519–529
  • , Reconstitution of bacteriorhodopsin and ATP synthase from Micrococcus luteus into liposomes of the purified main tetraether lipid from Thermoplasma acidophilum: proton conductance and light-driven ATP synthesis
  • Freisleben H. J., Zwicker K., Jezek P., John G., Bettin B. A, Ring Nawroth K. T. Chem. Phys. Lipids 1995; 78(2)137–147
  • , Synthesis of short polyoxyethylene-based heterobifunctional crosslinking reagents. Application to the coupling of peptides to liposomes
  • Frisch B., Boeckler C., Schuber F. Bioconjugate Chem 1996; 7(2)180–186
  • , Glycol methacrylate embedding of alginate-polylysine microencapsulated pancreatic islets
  • Fritschy W. M., Gerrits P. O., Wolters G. H. J., Pasma A., De Van Schilfgaar R. Biotech. Histochem 1995; 70(4)188–193
  • , Effect of preparation conditions on size distribution and drug contents of nifedipine sustained-release microspheres
  • Fu Chongdong, Jiang Xuetao, Hu Jinhong, Zhang Wanguo. Zhongguo Yiyao Gongye Zazhi 1995; 26(11)490–493
  • , Osteotropic drug delivery system (ODDS) based on bisphosphonic prodrug
  • Fujisaki J., Tokunaga Y., Takahashi T., Shimojo F., Kagayama A., Hata T. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 562–563
  • , SRB1, a class B scavenger receptor, recognizes both negatively charged liposomes and apoptotic cells
  • Fukasawa M., Adachi H., Hirota K., Tsujimoto M., Arai H., Inoue K. Exp. Cell. Res 1996; 222(1)246–250
  • , Thermosensitive sterically stabilized liposomes: formulation and in vitro studies on mechanism of doxorubicin release by bovine serum and human plasma
  • Gaber M. H., Hong K., Huang S. K., Papahadjopoulos D. Pharm. Res 1995; 12(10)1407–1416
  • , Stealth liposomes and cancer targeting: a realistic compromise in drug delivery
  • Gabizon A. A. J. Liposome Res 1995; 5(4)705–710
  • , Cationic liposome-mediated gene transfer
  • Gao X., Huang L. Gene Ther 1995; 2(10)710–722
  • , Potentiation of cationic liposome-mediated gene delivery by polycations
  • Gao X., Huang L. Biochemistry 1996; 35(3)1027–1036
  • , Collagen as a delivery system for hydrophobic drugs: studies with cyclosporine
  • Gebhardt B. M., Kaufman H. E. J. Ocul. Pharmacol. Ther 1995; 11(3)319–327
  • , Hydrogels for colonic drug delivery: effect of synthetic route on physicochemical properties
  • Ghandehari H., Yeh P. Y., Kopeckova P., Kopecek J. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 28–29
  • , Design, synthesis, and biological evaluation of isocyanuratebased antifungal and macrolide antibiotic conjugates: iron transport-mediated drug delivery
  • Ghosh M., Miller M. J. Bioorg. Med. Chem 1995; 3(11)1519–1525
  • , Drug delivery in asthma: a comparison of spacers with a jet nebuliser
  • Gibson P. G., Wlodarczyk J. H., Borgas T. Aust. N. Z. J. Med 1995; 25(4)324–329
  • , Liposome-mediated drug targeting in topical and regional therapies
  • Margalit R. Crit. Rev. Ther. Drug Carrier Syst 1995; 12(2 & 3)233–261
  • , Regional drug delivery. I: Permeability characteristics of the rat 6-day-old air pouch model of inflammation
  • Martin S. W., Stevens A. J., Brennan B. S., Reis M. L., Gifford L. A., Rowland M., Houston J. B. Pharm. Res 1995; 12(12)1980–1986
  • , Cocaine hydrochloride in poly(L-lactide) microspheres potentiates effects on the locomotion of rats
  • Masinde L. E., Bertelsen G. A., Schlemmer R. F., Jr, Gulati A., Hickey A. J. Methods Find. Exp. Clin. Pharmacol 1995; 17(9)597–600
  • , Determination of free and liposome-associated doxorubicin and vincristine levels in plasma under equilibrium conditions employing ultrafiltration techniques
  • Mayer L. D., St Onge G. Anal. Biochem 1995; 232(2)149–157
  • , Polysialic acids: in vivo properties and possible uses in drug delivery
  • McCormack B., Gregoriadis G. NATO ASI Ser., Ser A 1994; 273: 139–145
  • , Evaluation in vitro and in vivo of cationic liposomeexpression construct complexes for cystic fibrosis gene therapy
  • McLachlan G., Davidson D. J., Stevenson B. J., Dickinson P., Davidson-Smith H., Dorin J. R., Porteous D. J. Gene. Ther 1995; 2(9)614–622
  • , Brain tissue reaction following intracerebral injection of free or liposomally encapsulated BSH
  • Mehta S. C., Olson J. J., Lu D. R. Drug Delivery 1995; 2(3/4)175–180
  • , Targeting of drugs to the liver
  • Meijer D. K., Molema G. Semin. Liver. Dis 1995; 15(3)202–256
  • , Drug targeting with glycoproteins and other peptide carriers: an overview
  • Meijer D. K. F. NATO ASI Ser:, Ser A 1994; 273: 1–30
  • , Influence of the level of lipid peroxidation and the pH value of liposomal suspension on its antibacterial activity
  • Melyantseva L. P., Kreines V. M., Bulgakov V. G. Zh. Mikrobiol. Epidemiol. Immunobiol 1995; 1: 6–10
  • , Modulation of daunorubicin intracellular accumulation in P-glycoprotein expressing MCF-7 human breast adenocarcinoma cells by thermosensitive-liposome encapsulation and hyperthermia
  • Merlin J. L., Marchal S., Ramacci C., Notter D., Vigneron C. Int. J. Hyperthermia 1995; 11(6)855–865
  • , Drug effects on intraocular pressure and vascular flow in the bovine perfused eye using radiolabelled microspheres
  • Millar J. C., Wilson W. S., Can R. D., Humphries R. G. J. Ocul. Pharmacol. Ther 1995; 11(1)11–23
  • , Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using 5-aminosalicylic acid pellets
  • Milojevic S., Newton J. M., Cummings J. H., Gibson G. R., Botham R. L., Ring S. G., Stockham M., Allwood M. C. J. Controlled Release 1996; 38(1)75–84
  • , Amylose as a coating for drug delivery to the colon: preparation and in vitro evaluation using glucose pellets
  • Milojevic S., Newton J. M., Cummings J. H., Gibson G. R., Botham R. L., Ring S. G., Stockham M., Allwood M. C. J. Controlled Release 1996; 38(1)85–94
  • , Introduction of murine II-4 gene into B16(F10) melanoma tumors by direct gene transfer with DNA-liposome complexes
  • Missol E., Sochanik A., Szala S. Cancer Lett 1995; 97(2)189–193
  • , A mechanistic study of ultrasonically-enhanced transdermal drug delivery
  • Mitragotri S., Edwards D. A., Blankschtein D., Langer R. J. Pharm. Sci 1995; 84(6)697–706
  • , Thermally gelling poloxamine Synperonic T908 solution as a vehicle for rectal drug delivery
  • Miyazaki S., Oda M., Takada M., Attwood D. Biol. Pharm. Bull 1995; 18(8)1151–1153
  • , Efficient gene transfer into mammalian cells using fusogenic liposome
  • Mizuguchi H., Nakagawa T., Nakanishi M., Imazu S., Nakagawa S., Mayumi T. Biochem. Biophys. Res. Commun 1996; 218(1)402–407
  • , The significance of membrane lipids in exocytosis: control of liposome-evoked amylase release from secretory granules isolated from the rat parotid gland
  • Mizuno K. M., Inokuchi H., Kameyama Y., Yashiro K., Shin S. O., Fujita A. J. Biochem. (Tokyo) 1995; 118(4)693–699
  • , DNA/liposome as drug delivery system in the gene therapy
  • Mizuno M., Yoshida J. Drug Delivery Syst 1995; 10(6)399–403
  • , Exploiting bone marrow microvascular structure for drug delivery and future therapies
  • Moghimi S. M. Adv. Drug. Delivery Rev 1995; 17(1)61–73
  • , Alpha-tocopherol encapsulated in liposomes
  • Mojovic L., Siler-Marinkovic S., Zaharijev J., Bugarski B. Hem. Ind 1995; 49(10)420–423
  • , Sugar specific delivery of drugs, oligonucleotides and genes
  • Monsigny M., Roche A. C., Midoux P., Mayer R. NATO ASI Ser., Ser A 1994; 273: 31–50
  • , Integrating cell transplantation and controlled drug delivery technologies to engineer liver tissue
  • Mooney D. J., Sano K., Kaufmann P. M., McNamara K., Vacanti J. P., Langer R. Mater. Res. Soc. Symp. Proc 1995; 385: 43–48, Polymer/Inorganic Interfaces 2
  • , Integrating cell transplantation and controlled drug delivery technologies to engineer liver tissue
  • Mooney D. J., Sano K., Kaufmann P. M., McNamara K., Vacanti J. P., Langer R. Mater. Res. Soc. Symp. Proc 1995; 394: 105–110, Polymers in Medicine and Pharmacy
  • , Fast solute release from photosensitive liposomes: an alternative to 'caged' reagents for use in biological systems
  • Morgan C. G., Bisby R. H., Johnson S. A., Mitchell A. C. FEBS Lett 1995; 375(1–2)113–116
  • , Liposome-entrapped phenytoin locally suppresses amygdaloid epileptogenic focus created by db-cAMP/EDTA in rats
  • Mori N., Kurokouchi A., Osonoe K., Saitoh H., Ariga K., Suzuki K., Iwata Y. Brain Res 1995; 703(1,2)184–190
  • , Site-dependent delivery of peptide drug in the gastrointestinal tract
  • Morishita M., Nagai T. Drug Delivery Syst 1995; 10(5)329–336
  • , Intramural delivery of agent via a novel drug-delivery sleeve. Histological and functional evaluation
  • Moura A., Lam J. Y., Hebert D., Kermode J. R., Grant G. W., Robitaille D., Klein E. J., Yock P. G., Simpson J. B., Kaplan A. V. Circulation 1995; 92(8)2299–2305
  • , Albumin nanospheres as carriers for passive drug targeting: an optimized manufacturing technique
  • Mueller B. G., Leuenberger H., Kissel T. Pharm. Res 1996; 13(1)32–37
  • , Solid lipid nanoparticles (SLN). An alternative colloidal carrier system for controlled drug delivery
  • Mueller R. H., Mehnert W., Lucks J. S., Schwarz C., Zur Muehlen A., Weyhers H., Freitas C., Ruehl D. Eur. J. Pharm. Biopharm 1995; 41(1)62–69
  • , Circumvention of multidrug resistance in neoplastic cells through scavenger receptor mediated drug delivery
  • Mukhopadhyay A., Mukhopadhyay B., Basu S. K. FEBS Lett 1995; 376(1–2)95–98
  • , Lipid dependent cardio-hemodynamic tolerability of liposomes in rats
  • Muschick P., Sachse A., Leike J., Wehrmann D., Krause W. J. Liposome Res 1995; 5(4)933–953
  • , Is control of distribution of liposomes between tumors and bone marrow possible?
  • Nagayasu A., Uchiyama K., Nishida T., Yamagiwa Y., Kawai Y., Kiwada H. Biochim. Biophys. Acta 1996; 1278(1)29–34
  • , Reconstitution of purified P-glycoprotein into liposomes
  • Naito M., Tsuruo T. J. Cancer Res. Clin. Oncol 1995; 121(9/10)582–586
  • , Fusogenic liposomes: a new system for gene transfer
  • Nakanishi M. Tanpakushitsu Kakusan Koso 1995; 40(17)2550–2555
  • , Fusogenic liposome-mediated gene transfer
  • Nakanishi M., Mizuguchi H. Igaku no Ayumi 1995; 175(9)631–634
  • , Liquid membrane as novel drug delivery system
  • Nakhare S., Vyas S. P., Jain N. K. East. Pharm 1994; 37(440)65–70
  • , Development of a dissolution-controlled, zero-order release, drug delivery system
  • Narasimhan B., Peppas N. A. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 1995; 36(2)160–161
  • , pH-responsive gelatin microspheres for oral delivery of anticancer drug methotrexate
  • Narayani R., Rao K. P. J. Appl. Polym. Sci 1995; 58(10)1761–1769
  • , Antimicrobial effect of lipin, a liposomal drug
  • Nasr A. N. Mikrobiol. Zh 1993; 55(6)62–65
  • , Influence of liposomes rich in unsaturated or saturated fatty acids on the growth of human xenotransplanted mammary carcinomas and on the levels of heart type fatty acid binding protein
  • Naundorf H., Zschiesche W., Reszka R., Fichtner I. In Vivo 1995; 9(3)247–251
  • , In vitro assessment of bioadhesion for periodontal and buccal drug delivery
  • Needleman I. G., Smales F. C. Biomaterials 1995; 16(8)617–624
  • , Time-dependent behavior of interstitial fluid pressure in solid tumors: implications for drug delivery
  • Netti P. A., Baxter L. T., Boucher Y., Skalak R., Jain R. K. Cancer Res 1995; 55(22)5451–5458
  • , Influence of nonionic liposomal composition on topical delivery of peptide drugs into pilosebaceous units: an in vivo study using the hamster ear model
  • Niemiec S. M., Ramachandran C., Weiner N. Pharm. Res 1995; 12(8)1184–1188
  • , Preparation and evaluation of a time-controlled release capsule made of ethylcellulose for colon delivery of drugs
  • Niwa K., Takaya T., Morimoto T., Takada K. J. Drug Target 1995; 3(2)83–89
  • , Aerosolization of lactide/glycolide copolymer (PLGA) nanospheres for pulmonary delivery of peptide-drugs
  • Niwa T., Takeuchi H., Hino T., Kawashima Y. Yakugaku Zasshi 1995; 115(9)732–741
  • , A novel drug delivery system for treatment of hormone dependent diseases. Leuplin. Monthly microcapsule-depot form of leuprorelin
  • Ogawa Y. Kagaku to Kogyo (Tokyo) 1995; 48(11)1361–1363
  • , Formulation and efficacy of liposome-encapsulated antibiotics for therapy of intracellular Mycobacterium avium infection
  • Oh Y. K., Nix D. E., Straubinger R. M. Antimicrob. Agents Chemother 1995; 39(9)2104–2111
  • , Gene therapy of brain tumor with DNA/liposome
  • Ohta S., Yoshida J. Igaku no Ayumi 1995; 175(9)701–704
  • , Biodegradable microspheres in drug delivery
  • Okada H., Toguchi H. Crit. Rev. Thee Drug Carrier Syst 1995; 12(1)1–99
  • , Stimuli-responsive polymers and their application to special and temporal controlled drug delivery system
  • Okano T. Drug Delivery Syst 1995; 10(5)355–361
  • , Permeability change of liposomal membrane induced by interleukin-1 alpha
  • Oku N., Saito N., Okada S., Watanabe N., Kobayashi Y. J. Biochem. (Tokyo) 1995; 118(4)832–835
  • , Activity of liposomal amphotericin B (AmBisome) in dogs naturally infected with Leishmania infantum
  • Oliva G., Gradoni L., Ciaramella P., De Luna R., Cortese L., Orsini S., Davidson R. N., Persechino A. J. Antimicrob. Chemother 1995; 36(6)1013–1019
  • , Liposomal encapsulation of foscarnet protects against hypocalcemia induced by free foscarnet
  • Omar R. F., Dusserre N., Desormeaux A., Poulin L., Tremblay M., Beauchamp D., Bergeron M. G. Antimicrob. Agents Chemother 1995; 39(9)1973–1978
  • , Poly(methacrylic acid)-induced liposome aggregation for measuring drug entrapment
  • Oto E. K., Zalipsky S., Quinn Y. P., Zhu G. Z., Uster P. S. Anal. Biochem 1995; 229(1)106–111
  • , A novel skeletal drug delivery system using self-setting calcium phosphate cement. 9: Effects of the mixing solution volume on anticancer drug release from homogeneous drug-loaded cement
  • Otsuka M., Matsuda Y., Fox J. L., Higuchi W. I. J. Pharm. Sci 1995; 84(6)733–736
  • , A new oral microsphere drug delivery system
  • Ottenbrite R. M., Zhao R., Milstein S. Macromol. Symp 1996; 101: 379–387, 5th International Polymer Conference “Challenges in Polymer Science and Technology”
  • , Liposomal cyclosporine. Characterization of drug incorporation and interbilayer exchange
  • Ouyang C., Choice E., Holland J., Meloche M., Madden T. D. Transplantation 1995; 60(9)999–1006
  • , Efficacy of sustained-release ciprofloxacin microspheres against device-associated Pseudomonas aeruginosa biofilm infection in a rabbit peritoneal model
  • Owusu A. G., Rogers J. A., Morck D. W., Olson M. E. J. Med. Microbiol 1995; 43(5)368–376
  • , Inert matrixes as controlled release dosage forms for oral drug delivery
  • Pabon-Gonzalez C. V., Frutos-Cabanillas P., Lastres-Garcia J. L., Frutos-Cabanillas G. Cienc. Pharm 1995; 5(6)249–258
  • , Chronokinetics of liposomal encapsulated ampicillin in fasting and nonfasting rats
  • Pardue R. L., White C. A. J. Pharm. Sci 1996; 85(3)309–312
  • , Epidermal enzymes as penetration enhancers in transdermal drug delivery?
  • Patil S., Singh P., Szolar-Platzer C., Maibach H. J. Pharm. Sci 1996; 85(3)249–252
  • , Bioadhesives for optimization of drug delivery
  • Peppas N. A., Robinson J. R. J. Drug Targeting 1995; 3(3)183–184
  • , Three-dimensional visualisation of the large bowel: a potential tool for assessing targeted drug delivery and colonic pathology
  • Perkins A. C., Mann C., Wilson C. G. Eur. J. Nucl. Med 1995; 22(9)1035–1038
  • , Pharmacodynamics of a liposomal preparation for local anesthesia
  • Peters H., Moll F. Arzneim. Forsch 1995; 45(12)1253–1256
  • , Codeine-induced histamine release in intact human skin monitored by skin microdialysis technique: comparison of intradermal injections with an atraumatic intraprobe drug delivery system
  • Petersen L. J., Nielsen H. J., Skov P. S. Clin. Exp. Allergy 1995; 25(1 1)1045–1052
  • , Transdermal delivery of drugs with differing lipophilicities using azone analogs as penetration enhancers
  • Phillips C. A., Michniak B. B. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 648–649
  • , Modulation of murine macrophage nitric oxide synthesis by liposomal phospholipids: correlation with liposome immune adjuvant activity
  • Phillips N. C., Gagne L. J. Drug Target 1995; 3(2)137–147
  • , Liposome design and vaccine development
  • Pietrobon P. J. F. Pharm. Biotechnol 1995; 6: 347–361, Vaccine Design
  • , Biosynthetic polyhydroxyalkanoates and their potential in drug delivery
  • Pouton C. W., Akhtar S. Adv. Drug Delivery Rev 1996; 18(2)133–162
  • , In previously immunized elderly adults inactivated influenza A (H1N1) virus vaccines induce poor antibody responses that are not enhanced by liposome adjuvant
  • Powers D. C., Hanscome P. J., Pietrobon P. J. Vaccine 1995; 13(14)1330–1335
  • , The effects of electric current applied to skin: a review for transdermal drug delivery
  • Prausnitz M. R. Adv. Drug Delivery Rev 1996; 18(3)395–425
  • , Larch arabinogalactan for hepatic drug delivery: isolation and characterization of a 9 kDa arabinogalactan fragment
  • Prescott J. H., Enriquez P., Jung C., Menz E., Groman E. V. Carbohydr. Res 1995; 278(1)113–128
  • , Liposomal incorporation changes the effect of 1,25-dihydroxyvitamin D3 on the phospholipase C signal transduction pathway and the eicosanoid cascade on keratinocytes in vitro
  • Pruefer K., Jirikowski G. F. Biochem. Pharmacol 1996; 51(3)247–252
  • , Use of nebulised liposomal amphotericin B in the treatment of Aspergillus fumigatus empyema
  • Purcell I. F., Corris P. A. Thorax 1995; 50(12)1321–1323
  • , Liposome-encapsulated hemoglobin: interactions with the mononuclear phagocytic system
  • Rabinovici R., Neville L., Feuerstein G., Rudolph A. S. Drug Targeting Delivery 1995; 6: 227–239
  • , Recent developments of collagen-based materials for medical applications and drug delivery systems
  • Rao K. P. J. Biomater. Sci., Polym. Ed 1995; 7(7)623–645
  • , A semisynthetic quillaja saponin as a drug delivery agent for aminoglycoside antibiotics
  • Recchia J., Lurantos M. H. A., Amsden J. A., Storey J., Kensil C. R. Pharm. Res 1995; 12(12)1917–1923
  • , Why pharmacokinetic model drug delivery?
  • Reves J. G., Jacobs J. R., Sladen R. Int. Anesthesiol. Clin 1995; 33: 29–43, 3, Computer-Assisted Continuous Infusion of Intravenous Anesthesia Drugs
  • , Depletion of thymic macrophages in the rat by liposomeencapsulated dichloromethylene diphosphonate
  • Rezzani R., Rodella L., Ventura R. G. Arch. Histol. Cytol 1995; 58(4)427–433
  • , Preparation and characterization of indomethacin-loaded microspheres
  • Richey T., Harris F. W. Polym. Prepr. (Am. Chem. Soc., Div. Polym. Chem.) 1995; 36(2)255–256
  • , Bioadhesive polymers for oral drug delivery
  • Rihova B., Rathi R. C., Kopeckova P., Kopecek J. Adv. Exp. Med. Biol 1995; 371B: 1491–1494
  • , Development of a vasopressin transdermal drug delivery system
  • Ritschel W. A. Int. J. Pharm. Adv 1995; 1(2)230–254
  • , Antisense oligonucleotide therapeutics: drug delivery and targeting
  • Rojanasakul Y. Adv. Drug Delivery Rev 1996; 18(2)115–131
  • , Nitric oxide inhibition of lipoxygenase-dependent liposome and low-density lipoprotein oxidation: termination of radical chain propagation reactions and formation of nitrogen-containing oxidized lipid derivatives
  • Rubbo H., Parthasarathy S., Barnes S., Kirk M., Kalyanaraman B., Freeman B. A. Arch. Biochem. Biophys 1995; 324(1)15–25
  • , Approaches and opportunities in colon-specific drug delivery
  • Rubinstein A. Crit. Rev Ther. Drug Carrier Syst 1995; 12(2 & 3)101–149
  • , The role of stratum corneum in electrically facilitated transdermal drug delivery. I. Influence of hydration, tape-stripping and delipidization on the DC electrical properties of skin
  • Ruddy S. B., Hadzija B. W. J. Controlled Release 1995; 37(3)225–238
  • , Administration of liposome-encapsulated hemoglobin as a red cell substitute: safety and efficacy of an artificial oxygen carrying fluid
  • Rudolph A. S. Drug Targeting Delivery 1995; 6: 217–225
  • , Significant differences in serum clearance, and anatomical and hepatocellular distribution of 125I-labeled neoglycoproteins—implications for rate of elimination and targeting of drugs
  • Rushfeldt C., Smedsroed B. Cells Hepatic Sinusoid 1995; 5: 252–255
  • , Enzyme replacement therapy in ENU2 phenylketonuric mice using oral microencapsulated phenylalanine ammonialyase: a preliminary report
  • Safos S., Chang T. M. S. Artif. Cells. Blood. Substit. Immobil. Biotechnol 1995; 23(6)681–692
  • , Preparation of ranitidine hydrochloride microcapsules and its biphasic release kinetics
  • Saha N., Pal T. K. Drug Delivery 1995; 2(3/4)215–220
  • , O/W lipid emulsions for parenteral drug delivery. II. Effect of composition on pharmacokinetics of incorporated drug
  • Sakaeda T., Kakutani N., Hirano K. J. Drug Targeting 1995; 3(3)221–230
  • , Eradication of interleukin 5-transfected J558L plasmacytomas in mice by hydrogen peroxide-generating Stealth liposomes
  • Samoszuk M. K., Wimley W. C., Nguyen V. Cancer Res 1996; 56(1)87–90
  • , Polymeric drug delivery systems
  • San Roman J., Gallardo A., Levenfeld B. Adv. Mater. (Weinheim, Ger) 1995; 7(2)203–208
  • , Interaction of cationic liposomes with skin bacteria
  • Sanderson N. M., Jones M. N. Biochem. Soc. Trans 1995; 23(4)561S
  • , The application of liposomes to antiviral therapy: passive immunity and immunomodulation
  • Saravolac E. G., Wong J. P. Drug Targeting Delivery 1995; 6: 51–67
  • , Syntheses of novel galactosyl ligands for liposomes and the influence of the spacer on accumulation in the rat liver
  • Sasaki A., Murahashi N., Yamada H., Morikawa A. Biol. Pharm. Bull 1995; 18(5)740–746
  • , Ophthalmic preservatives as absorption promoters for ocular drug delivery
  • Sasaki H., Nagano T., Yamamura K., Nishida K., Nakamura J. J. Pharm. Pharmacol 1995; 47(9)703–707
  • , Ocular permeability of FITC-dextran with absorption promoter for ocular delivery of peptide drug
  • Sasaki H., Yamamura K., Tei C., Nishida K., Nakamura J. J. Drug Target 1995; 3(2)129–135
  • , Intraduodenal immunization with microencapsulated CFA/II induces a delayed, anti-CFA/II, IgG antibody-secreting spleen cell response
  • Sau K., Reid R. H., McQueen C., Boedeker E. C., Nellore R., Dalai P., Bhagat H. R. Adv. Exp. Med. Biol 1995; 371B: 1469–1474
  • , Efficiency of in vivo gene transfection into transplanted rat heart by coronary infusion of HVJ liposome
  • Sawa Y, Suzuki K, Bai H. Z., Shirakura R., Morishita R., Kaneda Y., Matsuda H. Circulation Suppl 1995; 92(9)479–482
  • , Pharmacokinetics of iopromide liposomes in rabbits
  • Schuhmann-Giampieri G., Leike J., Sachse A., Krause W. Pharm. Res 1995; 12(7)1065–1071
  • , A phase II trial of doxorubicin HCI liposome injection in patients with advanced pancreatic adenocarcinoma
  • Schwartz G. K., Casper E. S. Invest. New Drugs 1995; 13(1)77–82
  • , Model features of a cardiac iontophoretic drug delivery implant
  • Schwendeman S. P., Labhasetwar V., Levy R. J. Pharm. Res 1995; 12(5)790–795
  • , Oral antitumour activity in murine L1210 leukaemia and pharmacological properties of liposome formulations of N4-alkyl derivatives of 1-beta-D-arabinofuranosylcytosine
  • Schwendener R. A., Horber D. H., Odermatt B., Schott H. J. Cancer Res. Clin. Oncol 1996; 122(2)102–108
  • , Embryotoxicity of free and liposome-encapsulated taxol in the chick
  • Scialli A. R., DeSesso J. M., Rahman A., Husain S. R., Goeringer G. C. Pharmacology 1995; 51(3)145–151
  • , Two-dimensional finite element analysis of a polymer gel drug delivery system
  • Segalman D. J., Witkowski W. R. Mater. Sci. Eng 1995; C2(4)243–249
  • , In vitro evaluation of transdermal drug delivery
  • Shah V. P., Lesko L. J., Williams R. L. Eur. J. Pharm. Biopharm 1995; 41(3)163–167
  • , A novel strategy affords high-yield coupling of antibody Fab' fragments to liposomes
  • Shahinian S., Silvius J. R. Biochim. Biophys. Acta 1995; 1239(2)157–167
  • , Azo polymeric hydrogels for colon targeted drug delivery
  • Shantha K. L., Ravichandran P., Rao K. P. Biomaterials 1995; 16(17)1313–1318
  • , Preparation and poly(lactic acid) microspheres containing 5- fluorouracil and tests of drug release
  • Shen Z., Zhu J., Wu L., Xiao Y., Cheng J., Wu Z., Li S. Zhongguo Yiyao Gongye Zazhi 1995; 26(7)306–309
  • , Influence of steric stabilization of liposome-encapsulated hemoglobin on Listeria monocytogenes host defense
  • Sherwood R. L., McCormick D. L., Zheng S., Beissinger R. L. Artif Cells Blood Substit. Immobil. Biotechnol 1995; 23(6)665–679
  • , Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy
  • Siegal T., Horowitz A., Gabizon A. J. Neurosurg 1995; 83(6)1029–1037
  • , Dextran hydrogels for colon-specific drug delivery. V. Degradation in human intestinal incubation models
  • Simonsen L., Hovgaard L., Mortensen P.-B., Brondsted H. Eur. J. Pharm. Sci 1995; 3(6)329–337
  • , Facilitated drug delivery during transdermal iontophoresis
  • Singh P., Anliker M., Maibach H. I. Curr. Probl. Dermatol 1995; 22: 184–188
  • , Iontophoresis: an alternative to the use of carriers in cutaneous drug delivery
  • Singh P., Maibach H. I. Adv. Drug Delivery Rev 1996; 18(3)379–394
  • , Drug delivery in asthma
  • Smith C. Br. J. Hosp. Med 1995; 54(1)33–34
  • , Intratumoral chemotherapy with a sustained-release drug delivery system inhibits growth of human pancreatic cancer xenografts
  • Smith J. P., Stock E., Orenberg E. K., Yu N. Y., Kanekal S., Brown D. M. Anticancer Drugs 1995; 6(6)717–726
  • , Interleukin-2 lipid microspheres. I. Development and evaluation of the colloidal drug carrier
  • Sorenson M. A., Zebede M., Anderson P. M., Rahman Y. E. Drug Delivery 1995; 2(314)198–206
  • , Interleukin-2 lipid microspheres. II. In vitro and in vivo assessment of a colloidal drug carrier containing interleukin-2
  • Sorenson M. A., Zebede M., Anderson P. M., Rahman Y. E. Drug Delivery 1995; 2(314)207–214
  • , Penetration of the blood-brain barrier: enhancement of drug delivery and imaging by bacterial glycopeptides
  • Spellerberg B., Prasad S., Cabellos C., Burroughs M., Cahill P., Tuomanen E. J. Exp. Med 1995; 182(4)1037–1043
  • , Regional drug delivery II: relationship between drug targeting index and pharmacokinetic parameters for three non-steroidal anti-inflammatory drugs using the rat air pouch model of inflammation
  • Stevens A. J., Martin S. W., Brennan B. S., McLachlan A., Gifford L. A., Rowland M., Houston J. B. Pharm. Res 1995; 12(12)1987–1996
  • , Liposomal drug delivery: possibilities for manipulation
  • Storm G., Bakker-Woudenberg I. A. J. M., Woodle M. C., Blume G., Nassander U. K., Vingerhoeds M. H., Haisma H., Crommelin D. J. A. NATO ASI Ser., Ser A 1994; 273: 129–138
  • , Vitamin D sites and mechanisms of action: a histochemical perspective. Reflections on the utility of autoradiography and cytopharmacology for drug targeting
  • Stumpf W. E. Histochem. Cell Biol 1995; 104(6)417–427
  • , Evaluation of an aliphatic polyurethane as a microsphere matrix for sustained theophylline delivery
  • Subhaga C. S., Ravi K. G., Sunny M. C., Jayakrishnan A. J. Microencapsul 1995; 12(6)617–625
  • , Study on lyophilized arabinoside liposomes
  • Sui Y., Liu B., Xia D. Zhongguo Yiyuan Yaoxue Zazhi 1995; 15(11)487–490
  • , Complement activation by liposome-encapsulated hemoglobin in vitro: the role of endotoxin contamination
  • Szebeni J., Wassef N. M., Rudolph A. S., Alving C. R. Artif. Cells Blood Substit. Immobil. Biotechnol 1995; 23(3)355–363
  • , Development of delivery systems for DNA drugs and possible obstacles to be overcome
  • Takakura Y., Hashida M. Drug Delivery Syst 1995; 10(6)391–398
  • , Properties of water-insoluble mitomycin C-albumin conjugate as a sustained release drug delivery system in mice inoculated with sarcoma 180
  • Tanaka T., Kaneo Y., Miyashita M., Shiramoto S. Biol. Pharm. Bull 1995; 18(12)1724–1728
  • , The effect of different dose levels of degradable starch microspheres (Spherex) on the distribution of a cytotoxic drug after regional administration to tumour-bearing rats
  • Teder H., Johansson C. J., D'Argy R., Lundin N., Gunnarsson P. O. Eur. J. Cancer 1995; 31A(10)1701–1705
  • , Enhancement of nonspecific resistance by liposome-encapsulated immunomodulators does not affect skin graft rejection in mice
  • ten Hagen T. L., Vossen A. C, van Vianen W., Tibbe G. J., Savelkoul H. F., Heremans H., Bakker-Woudenberg I. A. Transplantation 1995; 60(11)1211–1214
  • , Prophylactic and therapeutic effects of liposome entrapped carboplatin for metastatic liver cancer. Study on intraportal administration
  • Terada J. Nagoya-shiritsu Daigaku Igakkai Zasshi 1995; 46(4)459–467
  • , Biodegradable indium-111 labeled microspheres for in vivo evaluation of distribution and elimination
  • Thanoo B. C., Doll W. J., Mehta R. C., Digenis G. A., DeLuca P. P. Pharm. Res 1995; 12(12)2060–2064
  • , Circumventing transport-associated resistance through drug delivery
  • Thierry A. R. Infect. Dis. Ther 1995; 17: 613–628
  • , Quantitative analysis of the olfactory pathway for drug delivery to the brain
  • Thorne R. G., Emory C. R., Ala T. A., Frey W. H., 2nd. Brain Res 1995; 692(1–2)278–282
  • , Metabolism of peptide drugs by the microorganisms in rat cecal contents and colon-specific delivery of insulin from chitosan capsules in rats
  • Tohzaki H., Fujita T., Murakami M., Yamamoto A., Muranishi S. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 498–499
  • , New synthetic amphiphilic polymers for steric protection of liposomes in vivo
  • Torchilin V. P., Trubetskoy V. S., Whiteman K. R., Caliceti P., Ferruti P., Veronese F. M. J. Pharm. Sci 1995; 84(9)1049–1053
  • , In vivo visualizing of organs and tissues with liposomes
  • Torchilin V. P., Trubetskoy V. S. J. Liposome Res 1995; 5(4)795–812
  • , Targeting of drugs and drug carriers within the cardiovascular system
  • Torchilin V. P. Adv. Drug Delivery Rev 1995; 17(1)75–101
  • , Heat-stabilized albumin microspheres as a sustained drug delivery system for the antimetabolite, 5-fluorouracil
  • Truter E. J. Artif. Cells Blood Substit. Immobil. Biotechnol 1995; 23(5)579–586
  • , Regulation of tetracycline hydrochloride release from polyacrylate microspheres. The mechanism of release
  • Tsankov S., Lambov N., Minkov E. Pharm. Ind 1995; 57(12)1044–1047
  • , Particle size studies for subcutaneous delivery of poly(lactide-co-glycolide) microspheres containing ovalbumin as vaccine formulation
  • Uchida T., Goto S., Foster T. P. J. Pharm. Pharmacol 1995; 47(7)556–560
  • , Instability of bovine insulin in poly(lactide-co-glycolide) (PLGA) microspheres
  • Uchida T., Yagi A., Oda Y., Nakada Y., Goto S. Chem. Pharm. Bull. (Tokyo) 1996; 44(1)235–236
  • , Polymeric conjugates of drugs and antibodies for site-specific drug delivery
  • Ulbrich K., Strohalm J., Subr V., Plocova D., Duncan R., Rihova B. Macromol. Symp 1996; 103: 177–192, Polymers and Medicine
  • , Enhanced tumor targeting and improved antitumor activity of doxorubicin by long-circulating liposomes containing amphipathic poly (ethylene glycol)
  • Unezaki S., Maruyama K., Ishida O., Suginaka A., Hosoda J.-I., Iwatsuru M. Int. J. Pharm 1995; 126(1,2)41–48
  • , Kinetic aspects in the design of prolonged action ocular drug delivery systems
  • Urtti A. Adv. Pharm. Sci 1995; 7: 63–92
  • , Effect and safety of liposome-encapsulated hemoglobin neo red cells (NRCs) as a perfusate for total cardiopulmonary bypass
  • Usuba A., Motoki R., Ogata Y., Suzuki K., Kamitani T. Artif. Cells Blood Substit. Immobil. Biotechnol 1995; 23(3)337–346
  • , Prevention of metastasis from mouse mammary carcinomas with liposomes carrying doxorubicin
  • Vaage J., Donovan D., Loftus T., Working P. Br. J. Cancer 1995; 72(5)1074–1075
  • , Liposome-encapsulated muramyl tripeptide phosphatidylethanolamine adjuvant immunotherapy for splenic hemangiosarcoma in the dog: A randomized multi-institutional clinical trial
  • Vail D. M., MacEwen G., Kurzman I. D., Dubielzig R. R., Helfand S. C., Kisseberth W. C., London C. A., Obradovich J. E., Madewell B. R., et al. Clin. Cancer Res 1995; 1(10)1165–1170
  • , Steroid drug delivery systems in endocrine and metabolic research: evaluation of three models
  • van Breda E., Menheere P. P., Geurten P., Keizer H. A. Horm. Metab. Res 1995; 27(9)436–437
  • , Hyperthermia enhances tumor uptake and antitumor efficacy of thermostable liposomal daunorubicin in a rat solid tumor
  • van Bree C., Krooshoop J. J., Rietbroek R. C., Kipp J. B., Bakker P. J. Cancer Res 1996; 56(3)563–568
  • , PCR monitoring of response to liposomal amphotericin B treatment of systemic candidiasis in neutropenic mice
  • van Deventer A. J. M., Goessens W. H. F., van Belkum A., van Etten E. W. M., van Vlie H. J. A., Verbrugh H. A. J. Clin. Microbiol 1996; 34(1)25–28
  • , Amphotericin B liposomes with prolonged circulation in blood: in vitro antifungal activity, toxicity, and efficacy in systemic candidiasis in leukopenic mice
  • van Etten E. W., ten Kate M. T., Stearne L. E., Bakker-Woudenberg I. A. Antimicrob. Agents Chemother 1995; 39(9)1954–1958
  • , Interactions of liposomal amphotericin B with extracellular and intracellular Candida albicans
  • van Etten E. W. M., Chander H. R., Snijders S. V., Bakker-Woudenberg I. A. J. M. J. Antimicrob. Chemother 1995; 36(6)961–974
  • , Morphological observations on the fate of liposomes in the regional lymph nodes after footpad injection into rats
  • Velinova M., Read N., Kirby C., Gregoriadis G. Biochim. Biophys. Acta 1996; 1299(2)207–215
  • , Preparation and characterization of dextran magnetite-incorporated thermosensitive liposomes: an on-line flow system for quantifying magnetic responsiveness
  • Viroonchatapan E., Ueno M., Sato H., Adachi I., Nagae H., Tazawa K., Horikoshi I. Pharm. Res 1995; 12(8)1176–1183
  • , Effect of composition and method of preparation of liposomes on their stability and interaction with murine monocytes infected with Brucella abortus
  • Vitas A. I., Diaz R., Gamazo C. Antimicrob. Agents Chemother 1996; 40(1)146–151
  • , Peptide-mediated release of folate-targeted liposome contents from endosomal compartments
  • Vogel K., Wang S., Lee R. J., Low P. S., Chmielewski J. J. Am. Chem. Soc 1996; 118(7)1581–1586
  • , A method for targeted intracellular delivery of drugs and genes: a novel utilization of immunoliposomes
  • Vural I., Narula J., Torchilin V. P., Khaw B. A. Proc. Int. Symp. Controlled Release Bioact. Mater 1995; 22nd: 450–451
  • , Antioxidant-surfactant liposomes mitigate hyperoxic lung injury in premature rabbits
  • Walther F. J., David C. R., Lopez S. L. Am. J. Physiol 1995; 269(5 Pt 1)L613–617
  • , Adverse effects at adjuvant treatment of liver metastases in rat with RSU-1069 + microspheres, or liposomal MTP-PE
  • Wang L., Roos G., Stenram U. Anticancer Res 1995; 15(5B)2077–2080
  • , Antitumor effects of direct IL-2 gene transfer into tumor by liposome and its induction of local immune response
  • Wang Q., Cao X., Zhang W., Zhou Z. M. S., Yie T. Zhongguo Mianyixue Zazhi 1995; 11(5)290–293; 297
  • , Flameless atomic absorption spectrometric determination of cisplatin content in cisplatin chitosan microspheres for targeting drug delivery
  • Wang Y., Shi T. Zhongguo Yaoxue Zazhi 1995; 30(10)618–620
  • , Targeted liposomes in fungi: modifying the therapeutic index of amphotericin B by its incorporation into negatively charged liposomes
  • Wasan K. M., Lopez-Berestein G. J. Liposome Res 1995; 5(4)883–903
  • , Toxic effects of antileishmanial reverse-phase evaporation liposomes containing dicetyl phosphate in monkeys
  • Wassef N. M., Swartz G. M., Berman J. D., Wilhelmsen C. L., Alving C. R. Drug Delivery 1995; 2(3/4)181–189
  • , Tissue electroporation for localized drug delivery
  • Weaver J. C., Langer R., Potts R. O. Adv. Chem. Ser 1995; 250: 301–316, Electromagnetic Fields
  • , The cationic lipid stearylamine reduces the permeability of the cationic drugs verapamil and prochlorperazine to lipid bilayers: implications for drug delivery
  • Webb M. S., Wheeler J. J., Bally M. B., Mayer L. D. Biochim. Biophys. Acta 1995; 1238(2)1471–1455
  • , Information resources for liposome research: the drug discovery program of the U.S. National Cancer Institute
  • Weinstein J. N., Myers T. G. J. Liposome. Res 1995; 5(4)837–844
  • , Antibody and cytotoxic T-lymphocyte responses to a single liposome-associated peptide antigen
  • White W. I., Cassatt D. R., Madsen J., Burke S. J., Woods R. M., Wassef N. M., Alving C. R., Koenig S. Vaccine 1995; 13(12)1111–1122
  • , Differential effects of methotrexate and liposomally conjugated methotrexate in rat adjuvant-induced arthritis
  • Williams A. S., Camilleri J. P., Amos N., Williams B. D. Clin. Exp. Immunol 1995; 102(3)560–565
  • , Pharmacokinetics and blood-brain barrier transport of (3H)-biotinylated phosphorothioate oligodeoxynucleotide conjugated to a vector-mediated drug delivery system
  • Wu D., Boado R. J., Pardridge W. M. J. Phartnacol. Exp. Ther 1996; 276(1)206–211
  • , Pharmaceutical and biological properties of doxorubicin encapsulated in liposomes (L-ADM): the effect of repeated administration on the systemic phagocytic activity and pharmacokinetics
  • Yachi K., Kikuchi H., Suzuki N., Atsumi R., Aonuma M., Kawato Y. Biopharm. Drug Dispos 1995; 16(8)653–667
  • , Distribution of liposomes containing mannobiose esters of fatty acid in rats
  • Yachi K., Kikuchi H., Yamauchi H., Hirota S., Tomikawa M. J. Microencapsul 1995; 12(4)377–388
  • , Cationic liposomes
  • Yagi K. Tanpakushitsu Kakusan Koso 1995; 40(17)2577–2582
  • , Gene transfer by cationic liposomes
  • Yagi K. Igaku no Ayumi 1995; 175(9)635–637
  • , Percutaneous internal maxillary arterial embolization with ethylcellulose microspheres. Results in an animal model
  • Yang J., Ma X. C., Zou Z. J., Wu Q. G., Wei S. L. Invest. Radiol 1995; 30(6)354–358
  • , Zero-order release kinetics from a self-correcting floatable asymmetric configuration drug delivery system
  • Yang L., Fassihix R. J. Pharm. Sci 1996; 85(2)170–173
  • , The use of liposomes in the therapy of liver disease
  • Yao T., Huang L., Zern M. A. Adv. Drug Delivery Rev 1995; 17(3)239–246
  • , Adsorption of BSA on highly carboxylated microspheresquantitative effects of surface functional groups and interaction forces
  • Yoon J. Y., Park H. Y., Kim J. H., Kim W. S. J. Colloid. Interface Sci 1996; 177(2)613–620
  • , Drug release from poly(dl-lactide) microspheres controlled by gamma-irradiation
  • Yoshioka S., Aso Y., Kojima S. J. Controlled Release 1995; 37(3)263–267
  • , Photodynamic therapy of pigmented choroidal melanomas using a liposomal preparation of benzoporphyrin derivative
  • Young L. H., Howard M. A., Hu L. K., Kim R. Y., Gragoudas E. S. Arch. Ophthalmol 1996; 114(2)186–192
  • , pH-sensitive drug delivery system using O/W emulsion
  • Yuk S. H., Cho S. H., Lee H. B. J. Controlled Release 1995; 37(1–2)69–74
  • , Evaluation of blood clearance rates and biodistribution of poly(2-oxazoline)-grafted liposomes
  • Zalipsky S., Hansen C. B., Oaks J. M., Allen T. M. J. Pharm. Sci 1996; 85(2)133–137
  • , Mixed lymphocyte islet culture for assessment of immunoprotection by islet microencapsulation
  • Zekorn T., Endl U., Horcher A., Siebers U., Bretzel R. G., Federlin K. Transplant Proc 1995; 27(6)3362–3363
  • , EPD, a novel technology for drug delivery
  • Zhao X. Adv. Drug Delivery Rev 1995; 17(3)257–262
  • , Preclinical toxicity of liposome-incorporated annamycin: selective bone marrow toxicity with lack of cardiotoxicity
  • Zou V., Priebe W., Stephens L. C., Perez-Soler R. Clin. Cancer Res 1995; 1(11)1369–1374

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.